Financial Performance - Operating revenue for Q1 2025 was CNY 209,602,506.82, down 26.28% from CNY 284,309,844.38 in Q1 2024[10] - Net profit attributable to shareholders for Q1 2025 was CNY 5,838,680.16, a decline of 41.24% compared to CNY 9,931,547.83 in the same period last year[10] - Total operating revenue for Q1 2025 was ¥209.60 million, a decrease of 26.3% compared to ¥284.31 million in Q1 2024[38] - Net profit for Q1 2025 was ¥5.84 million, a decline of 41.5% from ¥9.92 million in Q1 2024[39] - The company's total profit for Q1 2025 was approximately ¥2.06 million, down from ¥11.34 million in Q1 2024, reflecting a decrease of about 81.8%[42] Cash Flow - The net cash flow from operating activities increased by 155.41% to CNY 39,311,230.88, compared to a negative cash flow of CNY 70,949,432.04 in Q1 2024[10] - The net cash flow from operating activities was $8,393,425.38, a significant improvement compared to a net outflow of $78,804,482.05 in the previous period[47] - Total cash outflow from operating activities amounted to $262,237,142.15, down from $366,317,963.12 year-over-year[47] - The cash flow from financing activities for Q1 2025 was negative at approximately -¥42.00 million, compared to -¥42.26 million in Q1 2024, showing a slight improvement[45] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 757,312,611.39, a decrease of 3.46% compared to the end of 2024[10] - The company's total liabilities to assets ratio decreased to 15.27% from 18.95% year-over-year[10] - The total liabilities decreased from CNY 148,669,835.46 to CNY 115,668,371.51, a reduction of about 22.19%[32] - Current assets totaled CNY 475,001,642.08, down from CNY 501,359,228.85, indicating a decrease of about 5.25%[29] Shareholder Information - The largest shareholder, Yao Hong, holds 22,855,369 shares, representing 13.95% of the total shares[17] - Zheng Gang, another significant shareholder, holds 7,850,000 shares, accounting for 4.79% of the total shares[18] - The total number of shares held by the top ten shareholders is 59,801,282, which constitutes 36.51% of the total shares[18] Research and Development - Research and development expenses decreased by 51.06% to CNY 1,132,626.58, attributed to reduced material requisition during the reporting period[12] - Research and development expenses for Q1 2025 were approximately ¥1.04 million, a decrease from ¥1.99 million in Q1 2024, reflecting a reduction of about 47.9%[42] Legal and Compliance - The company received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws on March 21, 2025[26] - The company has no ongoing litigation or arbitration matters during the reporting period[22] - The company has fulfilled all disclosed commitments without any overdue or violations[25] Other Financial Metrics - The weighted average return on equity based on net profit attributable to shareholders was 0.91%, down from 1.31% in the previous year[10] - Basic earnings per share for Q1 2025 were ¥0.04, compared to ¥0.05 in Q1 2024[40] - The company reported a financial expense of -¥835,943.23 in Q1 2025, an improvement from -¥1,030,544.23 in Q1 2024[38]
凯大催化(830974) - 2025 Q1 - 季度财报